drugset
drugset / Trial / NCT00683501

Safety, Efficacy, and Pharmacokinetic Profile of DNB-001 in Subjects With Elevated Intraocular Pressure

NCT00683501 ↗

Phase 1/2 Completed 54 enrolled Danube Pharmaceuticals, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A Multi-Centre, Double-Blind, Randomised, Parallel-Group, Placebo-Controlled Phase 1I Study to Investigate the Safety, Efficacy, and Pharmacokinetic Profile of Twice-Daily DNB-001 in Previously Untreated Patients with intraocular Hypertension

Timeline

Start
2007-10
Primary completion
2008-08
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject DNB-001 Unknown — Oral

Indications

glaucoma ocular hypertension